The TRIM8 downregulation observed in ccRCC patients is due to the up-regulation of the miR-17-5p and miR-106b-5p, whose overexpression is promoted by the oncogene MYC-N [74] (Figure 2). This evidence concerns the gene TRIM8 and nonpapillary renal cell carcinoma.